Tokyo, March 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060607) titled 'A registry study of chemotherapy-ineligible metastatic hormone-sensitive prostate cancer' on March 1.
Study Type:
Observational
Primary Sponsor:
Institute - Sapporo Medical University School of Medicine
Condition:
Condition - metastatic hormone-sensitive prostate cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To investigate current treatment practices and prognoses for hormone-sensitive prostate cancer with metastases that does not undergo chemotherapy.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit ...